These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 26583099)

  • 1. Th17 Cell Plasticity and Functions in Cancer Immunity.
    Guéry L; Hugues S
    Biomed Res Int; 2015; 2015():314620. PubMed ID: 26583099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paradox of Th17 cell functions in tumor immunity.
    Asadzadeh Z; Mohammadi H; Safarzadeh E; Hemmatzadeh M; Mahdian-Shakib A; Jadidi-Niaragh F; Azizi G; Baradaran B
    Cell Immunol; 2017 Dec; 322():15-25. PubMed ID: 29103586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of T helper 17 and regulatory T cells in tumor microenvironment.
    Najafi S; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):16-24. PubMed ID: 30714422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer.
    Iida T; Iwahashi M; Katsuda M; Ishida K; Nakamori M; Nakamura M; Naka T; Ojima T; Ueda K; Hayata K; Nakamura Y; Yamaue H
    Oncol Rep; 2011 May; 25(5):1271-7. PubMed ID: 21369705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer.
    Song Y; Yang JM
    Biochem Biophys Res Commun; 2017 Nov; 493(1):1-8. PubMed ID: 28859982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment.
    Renaude E; Kroemer M; Loyon R; Binda D; Borg C; Guittaut M; Hervouet E; Peixoto P
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation.
    Stewart CA; Metheny H; Iida N; Smith L; Hanson M; Steinhagen F; Leighty RM; Roers A; Karp CL; Müller W; Trinchieri G
    J Clin Invest; 2013 Nov; 123(11):4859-74. PubMed ID: 24216477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of Th17 cells in anti-cancer immunity].
    Hus I; Maciag E; Roliński J
    Postepy Hig Med Dosw (Online); 2010 May; 64():244-50. PubMed ID: 20498501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cancer versus cancer-promoting effects of the interleukin-17-producing T helper cells.
    Hemdan NY
    Immunol Lett; 2013 Jan; 149(1-2):123-33. PubMed ID: 23159638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10: master switch from tumor-promoting inflammation to antitumor immunity.
    Oft M
    Cancer Immunol Res; 2014 Mar; 2(3):194-9. PubMed ID: 24778315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional plasticity of Th17 cells: implications in gastrointestinal tract function.
    Garrido-Mesa N; Algieri F; Rodríguez Nogales A; Gálvez J
    Int Rev Immunol; 2013; 32(5-6):493-510. PubMed ID: 24040751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Do Th17 cells play an important role in the pathogenesis and prognosis of ovarian cancer?].
    Winkler I; Gogacz M; Rechberger T
    Ginekol Pol; 2012 Apr; 83(4):295-300. PubMed ID: 22712263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis.
    Qian X; Chen H; Wu X; Hu L; Huang Q; Jin Y
    Cytokine; 2017 Jan; 89():34-44. PubMed ID: 26883678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-regulated Th17 plasticity in human health and diseases.
    Cerboni S; Gehrmann U; Preite S; Mitra S
    Immunology; 2021 May; 163(1):3-18. PubMed ID: 33064842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the interleukin-17 immune axis for cancer immunotherapy.
    Vitiello GA; Miller G
    J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31727783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells.
    Du R; Zhao H; Yan F; Li H
    J Leukoc Biol; 2014 Jul; 96(1):39-48. PubMed ID: 24744433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer.
    Chang SH
    Arch Pharm Res; 2019 Jul; 42(7):549-559. PubMed ID: 30941641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of T cell lineage commitment by SMAR1 during inflammatory & autoimmune diseases.
    Mirlekar B; Majumdar S; Khetmalas M; Chattopadhyay S
    Indian J Med Res; 2015 Oct; 142(4):405-13. PubMed ID: 26609032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?
    Martin F; Apetoh L; Ghiringhelli F
    Trends Mol Med; 2012 Dec; 18(12):742-9. PubMed ID: 23083809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.